Truepoint, Inc. Gilead Sciences, Inc. Transaction History

Truepoint, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$73.27 - $83.09 $252,048 - $285,829	3,440 New	3,440 $278,000
Q4 2017 Feb 05, 2018	SELL	$71.15 - $83.52 $49,805 - $58,464	-700 Closed	0 $0
Q3 2017 Nov 21, 2017	SELL	$72.11 - $85.47 $4.04 Million - $4.79 Million	-56,014 Reduced 98.77%	700 $57,000
Q3 2017 Nov 17, 2017	BUY	$72.11 - $85.47 $4.09 Million - $4.85 Million	56,714	56,714 $57,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Truepoint, Inc., based on Form 13F filings with the SEC.

Stay updated on Truepoint, Inc. with notifications on news.